Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-7-15
pubmed:abstractText
In pregnancy, a normal result on the oral glucose tolerance test (OGTT) that follows an abnormal screening glucose challenge test (GCT) is considered a reassuring finding, requiring no further intervention. The obstetrical and metabolic implications of this presentation, however, have not been well studied. Thus, we sought to characterize the obstetrical and postpartum metabolic significance of an abnormal GCT in women with normal glucose tolerance (NGT) on antepartum OGTT. DESIGN/PATIENTS/MEASUREMENTS: A total of 259 women with NGT on antepartum OGTT (166 with an abnormal GCT and 93 with a normal GCT) underwent (i) metabolic evaluation in pregnancy, (ii) assessment of obstetrical outcome at delivery and (iii) repeat metabolic characterization by OGTT at 3 months postpartum.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-10480510, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-10586979, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-11238474, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-11483845, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-11522706, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-11936316, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-12351492, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-12637977, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-14551018, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-14704259, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-15765129, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-15951574, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-16046308, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-16052327, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-16647897, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-18175247, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-18223032, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-18356402, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-18446658, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-18463375, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-18628572, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-2733939, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-510803, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-8092205, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-8846687, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-9360188, http://linkedlifedata.com/resource/pubmed/commentcorrection/19178531-9609584
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1365-2265
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
71
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
208-14
pubmed:dateRevised
2010-9-24
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
An abnormal screening glucose challenge test in pregnancy predicts postpartum metabolic dysfunction, even when the antepartum oral glucose tolerance test is normal.
pubmed:affiliation
Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Division of Endocrinology, University of Toronto, Toronto, Canada. rretnakaran@mtsinai.on.ca
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't